(044) ASSESSING THE EFFICACY OF INTRAURETHRAL BIMIX GEL AS AN ADJUNCT THERAPY IN 55 ERECTILE DYSFUNCTION PATIENTS

Abstract Introduction Erectile dysfunction can affect men from ages 40 to 70, with a range of 30% to 50% of the population experiencing this inability to achieve and sustain an erection (1). Erectile dysfunction can have a myriad of problems with risk factors such as obesity, smoking, and age, to name a few. The traditional treatments for ED are oral therapy, injections, and penile prostheses, but in some cases, these may not be effective. Objective To evaluate the effectiveness of intraurethral Bimix gel as an adjunct to therapy in 56 patients diagnosed with ED. Methods A retrospective chart review of patients who were prescribed intraurethral Bimix gel for a diagnosis of ED as an adjunct following primary therapy were selected. This yielded a total of 55 patients with a mean age of 61 (range, 25-85) years. The patients were prescribed intraurethral Bimix gel because of their unsatisfactory response to oral therapy. The efficacy of the gel was evaluated by comparing the Sexual Health Inventory for Men (SHIM) scores before and after the treatment with a Wilcoxon signed rank test. Results The mean SHIM score prior to intraurethral Bimix gel was 9.62 (range, 0-24), and following the Bimix gel administration was 11.93 (range, 1-25) (p < 0.001). The patients had a favorable response to the intraurethral Bimix gel therapy. This therapy offers a good alternative to patients and an easier mode of administration for patients who are wary of intracavernosal injections. One of the common side effects reported was a mild burning sensation at the administration site during the application and absorption period. There were no other adverse effects. Conclusions Intraurethral Bimix gel is a good alternative adjunct to primary oral therapy for erectile dysfunction which can be used together with the initial therapy or as a booster during the act of sexual intercourse as a salvage option. References 1. Khera, M., & Goldstein, I. (2011). Erectile dysfunction. BMJ Clinical evidence, 2011. Disclosure No.

Authors

Institutions

Publication Details

Journal
The Journal of Sexual Medicine
Published
2024-08-12
DOI
https://doi.org/10.1093/jsxmed/qdae167.042
Citations
1
Primary Topic
Urinary Bladder and Prostate Research
Type
article
Field-Weighted Citation Impact
0.54
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

(044) ASSESSING THE EFFICACY OF INTRAURETHRAL BIMIX GEL AS AN ADJUNCT THERAPY IN 55 ERECTILE DYSFUNCTION PATIENTS

Pushan Prabhakar, Alberto Queiróz Farias, José Arnaldo Shiomi da Cruz, D. Martínez et al.
1 citations
The Journal of Sexual Medicine
Urinary Bladder and Prostate Research
0.54
article

(044) ASSESSING THE EFFICACY OF INTRAURETHRAL BIMIX GEL AS AN ADJUNCT THERAPY IN 55 ERECTILE DYSFUNCTION PATIENTS

Pushan Prabhakar, Alberto Queiróz Farias, José Arnaldo Shiomi da Cruz, D. Martínez, J Caso, N Defauwes
article en
1 citations

Abstract

Abstract Introduction Erectile dysfunction can affect men from ages 40 to 70, with a range of 30% to 50% of the population experiencing this inability to achieve and sustain an erection (1). Erectile dysfunction can have a myriad of problems with risk factors such as obesity, smoking, and age, to name a few. The traditional treatments for ED are oral therapy, injections, and penile prostheses, but in some cases, these may not be effective. Objective To evaluate the effectiveness of intraurethral Bimix gel as an adjunct to therapy in 56 patients diagnosed with ED. Methods A retrospective chart review of patients who were prescribed intraurethral Bimix gel for a diagnosis of ED as an adjunct following primary therapy were selected. This yielded a total of 55 patients with a mean age of 61 (range, 25-85) years. The patients were prescribed intraurethral Bimix gel because of their unsatisfactory response to oral therapy. The efficacy of the gel was evaluated by comparing the Sexual Health Inventory for Men (SHIM) scores before and after the treatment with a Wilcoxon signed rank test. Results The mean SHIM score prior to intraurethral Bimix gel was 9.62 (range, 0-24), and following the Bimix gel administration was 11.93 (range, 1-25) (p < 0.001). The patients had a favorable response to the intraurethral Bimix gel therapy. This therapy offers a good alternative to patients and an easier mode of administration for patients who are wary of intracavernosal injections. One of the common side effects reported was a mild burning sensation at the administration site during the application and absorption period. There were no other adverse effects. Conclusions Intraurethral Bimix gel is a good alternative adjunct to primary oral therapy for erectile dysfunction which can be used together with the initial therapy or as a booster during the act of sexual intercourse as a salvage option. References 1. Khera, M., & Goldstein, I. (2011). Erectile dysfunction. BMJ Clinical evidence, 2011. Disclosure No.

The Journal of Sexual MedicineVol. 21(Supplement_7)
Tulane University (US), Cancer Institute (WIA) (IN), Baptist Health South Florida (US), Miami Heart Research Institute (US)
Openalex Percentile: Top 28%
Urinary Bladder and Prostate Research
0.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.